KAM
AMGN icon

Kazazian Asset Management’s Amgen AMGN Stock Holding History

Kazazian Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,702
Closed -$601K – 58
2015
Q4 		$601K Sell
3,702
-5,998
-62% -$943K 0.81% 18
2015
Q3 		$1.34M Buy
+9,700
New +$1.53M 1.69% 12

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kazazian Asset Management's AMGN Position: Q1 2016 in Review

Kazazian Asset Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 3,702 shares — an estimated $601K sold.

Kazazian Asset Management first reported a position in AMGN in Q3 2015 and held it in 2 quarters. The position peaked at $1.34M in Q3 2015. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Kazazian Asset Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Kazazian Asset Management sold 3,702 Amgen shares in Q1 2016, an estimated $601K.
  • Kazazian Asset Management first reported a position in Amgen in Q3 2015 and held it in 2 quarters.
  • Kazazian Asset Management's Amgen position peaked at $1.34M in Q3 2015.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Kazazian Asset Management's 13F filing for Q1 2016, filed 16 May 2016.